Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$780M |
| 2 |
Uber
UBER
|
+$708M |
| 3 |
Goldman Sachs
GS
|
+$569M |
| 4 |
Microsoft
MSFT
|
+$430M |
| 5 |
Netflix
NFLX
|
+$415M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$973M |
| 2 |
Intuitive Surgical
ISRG
|
+$872M |
| 3 |
Nike
NKE
|
+$844M |
| 4 |
Edwards Lifesciences
EW
|
+$805M |
| 5 |
Corpay
CPAY
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.66% |
| 2 | Consumer Discretionary | 19.04% |
| 3 | Healthcare | 13.04% |
| 4 | Communication Services | 12.22% |
| 5 | Financials | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Guidewire Software
GWRE
$13.3B
| $19.8M | 0.02% |
250,245
-157,782
| -39% | -$16.5M |
|
|
PINC
252
DELISTED
Premier
PINC
| $19.6M | 0.02% |
599,946
-56,822
| -9% | -$1.85M |
|
253
Newmont
NEM
$111B
| $19.6M | 0.02% |
433,218
-33,882
| -7% | -$1.53M |
|
254
Agios Pharmaceuticals
AGIO
$1.91B
| $19.6M | 0.02% |
552,729
+4,376
| +0.8% | +$202K |
|
255
Advance Auto Parts
AAP
$3.49B
| $19.6M | 0.02% |
210,062
-121,037
| -37% | -$15.7M |
|
256
PUT
iShares Russell 2000 ETF
IWM
$82.1B
| $19.5M | 0.02% |
+170,000
| New | +$25.3M |
|
257
PENN Entertainment
PENN
$2.69B
| $19.4M | 0.02% |
1,535,625
+273,800
| +22% | +$6.88M |
|
258
AXIS Capital
AXS
$7.62B
| $19.3M | 0.02% |
498,609
+25,266
| +5% | +$1.41M |
|
259
Enterprise Products Partners
EPD
$82.3B
| $19.2M | 0.02% |
1,344,520
-144,998
| -10% | -$3.37M |
|
|
SWAV
260
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $19.2M | 0.02% |
578,058
-2,276
| -0.4% | -$90.4K |
|
261
Dollar Tree
DLTR
$24.9B
| $18.9M | 0.02% |
256,942
-467,166
| -65% | -$39.8M |
|
262
Repligen
RGEN
$9B
| $18.8M | 0.02% |
194,711
+1,695
| +0.9% | +$164K |
|
|
GFLU
263
DELISTED
GFL Environmental Inc. Tangible Equity Units
GFLU
| $18.8M | 0.02% |
+410,427
| New | +$18.4M |
|
264
Prestige Consumer Healthcare
PBH
$2.58B
| $18.8M | 0.02% |
512,129
+71,517
| +16% | +$2.78M |
|
265
Aptiv
APTV
$9.61B
| $18.8M | 0.02% |
381,188
+46,145
| +14% | +$3.62M |
|
266
Insulet
PODD
$9.66B
| $18.6M | 0.02% |
112,184
+38,605
| +52% | +$7.05M |
|
|
ROIC
267
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $18.4M | 0.02% |
2,225,183
+46,516
| +2% | +$691K |
|
268
LiveRamp
RAMP
$2.3B
| $18.4M | 0.02% |
559,856
+286,724
| +105% | +$10.9M |
|
269
Independence Realty Trust
IRT
$4B
| $18.3M | 0.02% |
2,048,414
-7,672
| -0.4% | -$104K |
|
270
TSMC
TSM
$2.17T
| $18M | 0.02% |
377,683
+348
| +0.1% | +$19K |
|
|
SYNH
271
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $18M | 0.02% |
455,799
-117,629
| -21% | -$6.88M |
|
272
Novartis
NVS
$293B
| $17.8M | 0.02% |
215,883
-2,626,060
| -92% | -$234M |
|
273
First Bancorp
FBNC
$2.66B
| $17.6M | 0.02% |
762,514
+78,532
| +11% | +$2.57M |
|
274
Palo Alto Networks
PANW
$293B
| $17.5M | 0.02% |
640,860
-284,448
| -31% | -$9.93M |
|
275
Lockheed Martin
LMT
$135B
| $17.5M | 0.02% |
51,501
+11,563
| +29% | +$4.55M |
|
Similar funds
Jennison Associates's Q1 2020 Portfolio in Review
As of Q1 2020, Jennison Associates held 749 positions worth $82.3B, down 17% from $99.1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates withdrew a net $4.86B in Q1 2020, closing 131 positions and reducing 247 holdings. Its most notable exit was Parker-Hannifin, an estimated $116M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Atlassian worth $350M.
- Jennison Associates's largest Q1 2020 buy was Atlassian: 2,552,272 shares worth $350M.
- Jennison Associates added most to Eli Lilly in Q1 2020, an estimated $780M increase.
- Jennison Associates's biggest Q1 2020 reduction was Walt Disney, cutting an estimated $973M.
- Jennison Associates fully exited Parker-Hannifin in Q1 2020, selling an estimated $116M.
- Jennison Associates's ten largest holdings make up 40% of its $82.3B portfolio in Q1 2020.
- Jennison Associates opened 131 new positions and closed 131 in Q1 2020.
- Jennison Associates's portfolio value fell 17% quarter-over-quarter to $82.3B.
Based on Jennison Associates's 13F filing for Q1 2020, filed 6 May 2020.